PART Program
About Our StudiesEligibilityClinical ServicesWho We AreResourcesContact Us Make A Gift  

The staff at the PART program is dedicated to learning about how to identify individuals in the early phase of psychosis in the hope of delaying or preventing psychosis in individuals at clinical high risk and improving the course of psychosis in individuals who have already been diagnosed. Our team is comprised of staff and faculty at the University of California, San Francisco and the San Francisco Veterans Affairs Medical Center.

Rachel Loewy, Ph.D., Director Dr. Loewy is a clinical psychologist and Assistant Professor in the UCSF Department of Psychiatry. She has been working in the area of early psychosis research for over 15 years. She is interested in identifying risk factors for psychosis, particularly those related to the experience of stress and trauma, and also works to implement evidence-based treatments for early psychosis into typical community practice through the Prevention and Recovery in Early Psychosis (PREP) programs.

Demian Rose, M.D., Ph.D. Dr. Demian Rose is an Assistant Professor of Psychiatry at UCSF. He is the medical director of PART and of the UCSF Early Psychosis Clinic, which offers clinical services to interested PART subjects. His academic roles include direct patient care, teaching and supervision of trainees and curriculum design. He is also active in serving the community through the Prevention and Recovery in Early Psychosis (PREP) Program. His interests include: improving care for people with impairing psychosis, educating the current and next generations of clinicians in best practices for this population, and breaking down stigma through the use of empathy and scientific reasoning.

Daniel H. Mathalon, M.D. Dr. Mathalon is co-director and principal investigator of the Brain Imaging and EEG Laboratory at University of California, San Francisco, where he is on faculty. Dr. Mathalon’s research examines the brain abnormalities that underlie the symptoms and course of psychopathology, particularly schizophrenia. In addition to conducting research, Dr. Mathalon is an attending psychiatrist at the San Francisco VA Medical Center.

Danielle Schlosser, Ph.D. Danielle Schlosser is a clinical psychologist and an Assistant Professor of Psychiatry at UCSF. Her research is focused on improving the lives of young people with schizophrenia by using digital health interventions. Currently, Dr. Schlosser is conducting a NIMH-funded study on a Personalized Real-time Intervention for Motivational Enhancement (PRIME).

Joshua Woolley Joshua Woolley is a board certified psychiatrist and advanced neuroscience research fellow at the San Francisco VA Medical Center who received his Ph.D. in neuroscience and M.D. from the University of California, San Francisco. Dr. Woolley's research involves investigating methods to strengthen social support systems in patients with schizophrenia and how these methods can advance their treatment. Currently, he is examining the role of oxytocin as a potential biomarker for psychosis, its ability to affect dyadic family interactions, and its effectiveness in treating social cognitive deficits in adults and adolescents with psychosis.




If I am found to be psychotic, will I be able to do all the things I have wanted to do, like go to college and be independent?
Although each person's experience is different, for the most part, many of the individuals in our program are able to go to school and lead fulfilling lives.

About Our Studies |Eligibility|Clinical Services|Who We Are|Resources |Contact Us